SCHEMBL6892427

SCHEMBL6892427

CC(C)CCc1[c]c2ccccc2cc1

nearest known ligand 0.34

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.33
ESR1 P03372 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
BCHE P06276 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6894291 0.90 GRIN2D (0.34) BCHE
SCHEMBL3407567 0.87 HIF1A (0.34) BCHE
SCHEMBL6894362 0.85
SCHEMBL4608372 0.81 HTR2A (0.34)
SCHEMBL258245 0.79 KDM4E (0.33) KDM4EALDH1A1GAA
SCHEMBL258351 0.76 TLR8 (0.36) LMNAGAAKMT2ATDP1BCHE
SCHEMBL11424021 0.76 TDP1 (0.37) TDP1
SCHEMBL6038388 0.76 TAAR1 (0.37) ALDH1A1TDP1
SCHEMBL4841054 0.76 TDP1 (0.37) TDP1
SCHEMBL295333 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888262-B1 CYCLOALKYL DERIVATIVES AND THE SOLID-PHASE SYNTHESIS OF SUCH DERIVATIVES BASF AG (DE) 2004-06-02 EP disclosed
US-6521780-B1 Cycloalkylmalonic ester derivatives as potential active substances in the drugs and crop protection; combinatorial chemistry BASF AKTIENGESELLSCHAFT (DE) 2003-02-18 US disclosed
US-6469056-B1 VERY SELECTIVE INHIBITORS OF ENDOTHELIN CONVERTING ENZYME WITH ACTIVITIES IN THE PICOMOLAR RANGE FOR USE AS HYPOTENSIVE AGENTS ABBOTT LABORATORIES 2002-10-22 US disclosed
EP-0906324-B1 CARBOHYDRATE DERIVATIVES AND THEIR SOLID-PHASE SYNTHESIS BASF AG (DE) 2001-08-01 EP disclosed
US-6242583-B1 COUPLING CARBOHYDRATE COMPOUNDS IN PRESENCE OF PROMOTER TO A FUNCTIONALIZED SOLID SUPPORT BASF AKTIENGESELLSCHAFT (DE) 2001-06-05 US disclosed
EP-1023282-A1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS, THEIR PREPARATION AND USE AS ECE-INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2000-08-02 EP disclosed
EP-1023318-A1 DIPEPTIDES FOR THE TREATMENT OF DISEASES RELATED TO THE BIOLOGICAL EFFECT OF ENDOTHELIN BASF AKTIENGESELLSCHAFT (DE) 2000-08-02 EP disclosed
WO-1999019320-A1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS, THEIR PREPARATION AND USE AS ECE-INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1999-04-22 WO disclosed
WO-1999019346-A1 DIPEPTIDES FOR THE TREATMENT OF DISEASES RELATED TO THE BIOLOGICAL EFFECT OF ENDOTHELIN BASF AKTIENGESELLSCHAFT (DE) 1999-04-22 WO disclosed
EP-0906324-A1 CARBOHYDRATE DERIVATIVES AND THEIR SOLID-PHASE SYNTHESIS BASF AKTIENGESELLSCHAFT (DE) 1999-04-07 EP disclosed
EP-0888262-A1 CYCLOALKYL DERIVATIVES AND THE SOLID-PHASE SYNTHESIS OF SUCH DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1999-01-07 EP disclosed
WO-1997045436-A1 CARBOHYDRATE DERIVATIVES AND THEIR SOLID-PHASE SYNTHESIS BASF AKTIENGESELLSCHAFT (DE) 1997-12-04 WO disclosed
WO-1997034852-A1 CYCLOALKYL DERIVATIVES AND THE SOLID-PHASE SYNTHESIS OF SUCH DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1997-09-25 WO disclosed